Contract research
It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
News innovation
Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW
Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, announces the submission of its GalliaPharm® 6...
more ...Inspiring and connecting: “Talk im Cube”
For almost a year, “Talk im Cube” has been bringing science and business together on the Campus Berlin-Buch
more ...Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments
Eckert & Ziegler, one of the world’s largest providers of isotopes for medical, scientific and industrial use, and Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceuti...
more ...Events Campus
07.01.2025, 16:00
Krebs und Metastasierung: Ursachen und neue Therapien
26.02.2025, 10:00
JUGEND FORSCHT – 60. Regional-Wettbewerb „Macht aus Fragen Antworten”
Die Pateneinrichtungen des Campus Berlin-Buch richten erneut den Regionalwettbewerb aus
more ...12.03.2025, 08:30
vocatium Berlin focus 2025
Über Berufe und Bildungswege informieren: Fachmesse für Ausbildung+Studium MINT-Zukunftsberufe, Praktika, Freiwilliges Jahr
more ...
